Daily Archives: 08/02/2011

UCB cell tech PDL Biopharma Patent Disputes

Today UCB announced that they resolve all patent dispute with protein design lab (PDL Biopharma) and UCB will pay PDL US$ 10 million [UCB Press Release] On Feb 2005, USPTO declared  interference proceeding between certain claims of Queen et al U.S. Patent … Continue reading

Posted in Patent case | Tagged , , , , , | Leave a comment

CI & Patent News: 08/02/2011

1) Salix licenses RELISTOR from Progenics Pharmaceuticals (Press release); RELISTOR® (methylnaltrexone bromide) is opioid antagonist, indicated for treatment of opioid-induced constipation. “The methylnaltrexone license includes intellectual property from the University of Chicago, Progenics Pharmaceuticals, and Wyeth Pharmaceuticals, including patents and applications with expiration dates that will … Continue reading

Posted in Daily interesting IP news | 1 Comment